A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02208063
Recruitment Status : Terminated (Halted due to lack of statistical power. No safety concerns identified. Enrolled subjects were allowed to complete scheduled study activities.)
First Posted : August 4, 2014
Last Update Posted : October 4, 2018
Information provided by (Responsible Party):
Theravance Biopharma

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : April 12, 2018
  Actual Study Completion Date : April 12, 2018